Impact of Patisiran, an RNAi Therapeutic, on Orthostatic Intolerance in Patients With Hereditary Transthyretin-Mediated Amyloidosis
Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2019.07.222
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2019
Authors
Publisher
Elsevier BV